Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study
达雷妥尤单抗一线治疗在真实世界环境中使多发性骨髓瘤患者获益：一项多中心回顾性倾向评分匹配研究
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06808-5
Wang, Yun; Chen, Xiaoqin; Liang, Qi; Wang, Weida; Luo, Jun; Luo, Lin; Feng, Ru; Wei, Yongqiang; Tian, Yuyang; Du, Xin; Huang, Zhenqian; Hu, Guoyu; Fu, Xiangjun; Tao, Shi; Zhou, Jihao; Peng, Hongling; Su, Yongzhong; Zhang, Hongyu; Dong, Min; Lan, Mei; Sun, Zhiqiang; Wang, Xiuju; Zhou, Hui; Zhong, Liye; Peter Gale, Rober; Liang, Yang; Xia, Zhongjun
